Participant selection for preventive Regenerative Medicine trials: ethical challenges of selecting individuals at risk

The innovative field of Regenerative Medicine (RM) is expected to extend the possibilities of prevention or early treatment in healthcare. Increasingly, clinical trials will be developed for people at risk of disease to investigate these RM interventions. These individuals at risk are characterised...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical ethics 2015-11, Vol.41 (11), p.914-916
Hauptverfasser:	Niemansburg, Sophie L, Habets, Michelle G J L, Dhert, Wouter J A, van Delden, Johannes J M, Bredenoord, Annelien L
Format:	Artikel
Sprache:	eng
Schlagworte:	Arthritis Bioethics Clinical trials Clinical Trials as Topic - ethics Disease Disease prevention Ethical aspects Ethics Health risk assessment Humans Informed consent Informed Consent - ethics Intervention Medical research Medicine, Experimental Moral Obligations Opportunity costs Patient Selection - ethics Preventive Medicine - ethics Primary Prevention - ethics Regenerative medicine Regenerative Medicine - ethics Research ethics Risk Assessment Stem cells Uncertainty
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!